Professor David Ray to Lead Oxford Centre for Diabetes, Endocrinology, and Metabolism
In conjunction with this new role, he will also assume the Chair of the OCDEM Management Board. His leadership is expected to foster collaboration and advancements in the field of diabetes, endocrinology, and metabolism, driving innovative solutions for those living with cardiometabolic and endocrine diseases.
Expressing his enthusiasm for the appointment, David emphasised the importance of strengthening connections with major interdisciplinary research centres such as the Kavli Institute for Nanoscience Discovery, Oxford. He emphasised the shared commitment to improving the quality of life for individuals grappling with complex health challenges, reflecting the institute's dedication to groundbreaking research and interdisciplinary solutions.
For more details and insights, David further added, "I am thrilled to head up the Oxford Centre for Diabetes, Endocrinology, and Metabolism. The centre's efforts will be fortified through strategic collaborations, including those with the Kavli Institute, as we explore novel pathways to enhance the well-being of those affected by cardiometabolic and endocrine disorders."
Since April 2021, Oxford University's KAVLI Institute for Nanoscience Discovery is proudly serving as a hub for research groups from seven different departments spanning both the medical and physical sciences, including Professor David Ray's Group. Professor Ray is the co-Director of the Sir Jules Thorn Sleep and Circadian Neuroscience Institute.